Canaccord Genuity Reiterates a 'Buy' on Celestica (CLS); Q1/11; In-Line Quarter and Nice Acquisition
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Celestica (NYSE: CLS), PT $13.
Canaccord analyst says, "Celestica reported in-line Q1/11 results and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "Celestica reported in-line Q1/11 results and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
